Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124652872 | 12465287 | 2 | F | 20160705 | 20160725 | 20160614 | 20160802 | EXP | PHEH2016US014676 | NOVARTIS | 72.20 | YR | F | Y | 0.00000 | 20160802 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124652872 | 12465287 | 1 | PS | ZOMETA | ZOLEDRONIC ACID | 1 | Unknown | UNK | 21223 | ||||||||||
| 124652872 | 12465287 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 15 MG, PRN | 0 | 15 | MG | CAPSULE | |||||||
| 124652872 | 12465287 | 3 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 10 MG, QD (21 IN 28 D) | 0 | 10 | MG | CAPSULE | QD | ||||||
| 124652872 | 12465287 | 4 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 10 MG, QD (21 IN 28 D) | 0 | 10 | MG | CAPSULE | QD | ||||||
| 124652872 | 12465287 | 5 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 10 MG, QD (21 IN 28 D) THEN 7 DAYS OFF | 0 | 10 | MG | CAPSULE | QD | ||||||
| 124652872 | 12465287 | 6 | C | ACETAMINOPHEN W/HYDROCODONE BITARTRATE | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | 1 DF, Q6H | U | 0 | 1 | DF | TABLET | Q6H | |||||
| 124652872 | 12465287 | 7 | C | PROCHLORPERAZINE MALEATE. | PROCHLORPERAZINE MALEATE | 1 | Oral | 10 MG, Q6H PRN | U | 0 | 10 | MG | TABLET | Q6H | |||||
| 124652872 | 12465287 | 8 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 8 MG, Q12H PRN | U | 0 | 8 | MG | TABLET | Q12H | |||||
| 124652872 | 12465287 | 9 | C | MOUTH WASH | 2 | Unknown | 5 ML, MM QID PRN | U | 0 | 5 | ML | QID | |||||||
| 124652872 | 12465287 | 10 | C | CLONIDINE HCL | CLONIDINE HYDROCHLORIDE | 1 | Oral | 0.1 MG, Q12H 30 DAYS | U | 0 | .1 | MG | TABLET | Q12H | |||||
| 124652872 | 12465287 | 11 | C | AMLODIPINE BESILATE | AMLODIPINE BESYLATE | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | TABLET | QD | |||||
| 124652872 | 12465287 | 12 | C | VALSARTAN HCTZ | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | TABLET | QD | |||||
| 124652872 | 12465287 | 13 | C | LYRICA | PREGABALIN | 1 | Oral | 75 MG, Q12H | U | 0 | 75 | MG | CAPSULE | Q12H | |||||
| 124652872 | 12465287 | 14 | C | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Oral | 6 MG, QOD | U | 0 | 6 | MG | TABLET | ||||||
| 124652872 | 12465287 | 15 | C | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Oral | 4.5 MG, QOD | U | 0 | 4.5 | MG | TABLET | ||||||
| 124652872 | 12465287 | 16 | C | FOSAMAX | ALENDRONATE SODIUM | 1 | Oral | 70 MG, QW | U | 0 | 70 | MG | TABLET | /wk | |||||
| 124652872 | 12465287 | 17 | C | CITRACAL PLUS BONE DENSITY BUILDER | 2 | Oral | 1 DF, QD | U | 0 | 1 | DF | TABLET | QD | ||||||
| 124652872 | 12465287 | 18 | C | LOPRESSOR | METOPROLOL TARTRATE | 1 | Oral | 50 MG, BID | U | 0 | 50 | MG | TABLET | BID | |||||
| 124652872 | 12465287 | 19 | C | COUMADIN | WARFARIN SODIUM | 1 | Oral | 4.5 MG, QOD | U | 0 | 4.5 | MG | TABLET | ||||||
| 124652872 | 12465287 | 20 | C | COUMADIN | WARFARIN SODIUM | 1 | Oral | 6 MG, QOD | U | 0 | 6 | MG | TABLET | ||||||
| 124652872 | 12465287 | 21 | C | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | 15 U, BEDTIME | U | 0 | 15 | DF | SOLUTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124652872 | 12465287 | 1 | Product used for unknown indication |
| 124652872 | 12465287 | 2 | Plasma cell myeloma |
| 124652872 | 12465287 | 6 | Product used for unknown indication |
| 124652872 | 12465287 | 7 | Product used for unknown indication |
| 124652872 | 12465287 | 8 | Product used for unknown indication |
| 124652872 | 12465287 | 9 | Product used for unknown indication |
| 124652872 | 12465287 | 10 | Product used for unknown indication |
| 124652872 | 12465287 | 11 | Product used for unknown indication |
| 124652872 | 12465287 | 12 | Product used for unknown indication |
| 124652872 | 12465287 | 13 | Product used for unknown indication |
| 124652872 | 12465287 | 14 | Product used for unknown indication |
| 124652872 | 12465287 | 16 | Product used for unknown indication |
| 124652872 | 12465287 | 17 | Product used for unknown indication |
| 124652872 | 12465287 | 18 | Product used for unknown indication |
| 124652872 | 12465287 | 19 | Product used for unknown indication |
| 124652872 | 12465287 | 21 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124652872 | 12465287 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124652872 | 12465287 | Anaemia | |
| 124652872 | 12465287 | Arthritis | |
| 124652872 | 12465287 | Blood creatinine increased | |
| 124652872 | 12465287 | Blood pressure systolic increased | |
| 124652872 | 12465287 | Blood urea increased | |
| 124652872 | 12465287 | Cancer pain | |
| 124652872 | 12465287 | Cough | |
| 124652872 | 12465287 | Fatigue | |
| 124652872 | 12465287 | Hypoaesthesia | |
| 124652872 | 12465287 | Neutropenia | |
| 124652872 | 12465287 | Oedema | |
| 124652872 | 12465287 | Osteonecrosis of jaw | |
| 124652872 | 12465287 | Paraesthesia | |
| 124652872 | 12465287 | Plasma cell myeloma recurrent | |
| 124652872 | 12465287 | Platelet count decreased | |
| 124652872 | 12465287 | Skin discolouration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124652872 | 12465287 | 1 | 201409 | 0 | ||
| 124652872 | 12465287 | 3 | 201505 | 0 | ||
| 124652872 | 12465287 | 4 | 20150602 | 0 | ||
| 124652872 | 12465287 | 5 | 201512 | 0 |